Thanks to a collaboration between Columbia and Cornell doctors, Yasin Samad is one of the first children in the United States to receive an innovative artificial heart valve.
Robotic surgery is revolutionizing the landscape of surgical care, offering minimally invasive options that enhance precision, reduce recovery times, and expand treatment possibilities.
The rising complexity of heart disease requires new ways to treat it, including those that combine surgical and catheter-based approaches in the same patient.
A clinical trial based on discoveries made by researchers in Columbia’s Pancreas Center is showing promising results and is now expanding to include more patients.
An expanding artificial heart valve being developed by Columbia surgeons and engineers could simplify treatment for many kids born with congenital heart disease.
A new study shows that omitting aspirin from an anti-clotting regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots.
A minimally invasive procedure for fixing diseased aortic valves is just as safe and durable as traditional surgery after five years, a new study reports.